1

AI in Cardiovascular Imaging

Dr. Tim Leiner (Mayo Clinic)

Machine learning and especially deep learning hold great promise to improve patient care. In several domains, algorithms perform as good as or better than fellowship trained radiologists for identification of abnormalities in clinically acquired images. However, there are much broader applications beyond image analysis such as patient selection and examination scheduling, image acquisition and reconstruction, using image data for prognostic purposes, and combing image data with information from electronic health records, laboratory and genetic data. Furthermore, in order for algorithms to be broadly accepted, there are many scenarios where it is important for the clinician that results are explainable. In addition, clinical deployment and workflow should be taken into consideration when designing the algorithm and bringing it to clinical practice. In my lecture I will focus on these aspects from a cardiovascular imaging perspective.

2

IDC Update

Ulrike Wagner, FNLCR

3

TCIA Update

Justin Kirby, FNLCR

Dr. Tim Leiner

"AI in Cardiovascular Imaging"

2023 webinars

2022 webinars

2021 webinars

2020 webinars

2019 webinars

2018 webinars

2017 webinars

2016 webinars

2015 webinars

2014 webinars

2013 webinars

2012 webinars

ChatGPT and the potential healthcare implications of large language models

George Shih, MD, Weill Cornell Medicine

ChatGPT has exploded into our world and it has the potential to be a widely available near omniscient AI, including many applications in healthcare for providers, patients, researchers, educators, students, and healthcare companies.  In this talk, we'll explore examples of ChatGPT in healthcare, and discuss the potential impact and implications to stakeholders as ChatGPT evolves and improves over time.

Recording

Transcript

Radiation Dose Reduction in CT and its Effects on Quantitative Imaging and Machine Learning/Artificial Intelligence Algorithms

Dr. Michael McNitt-Gray, UCLA

CT is widely used in clinical practice with applications ranging from early detection (screening), characterization (diagnosis) and assessment of response to therapy. There has been widespread concern over the radiation dose associated with these scans, especially on pediatric patients or patients who get frequent scans. There have been significant developments which allow the reduction of radiation dose from CT including developments in automatic exposure control, advanced image reconstruction techniques , more efficient detector technologies among others that promise significant radiation dose reductions to patients, while maintaining clinical image quality.  While these technologies are exquisite and should be investigated wherever possible in a clinical environment, their effects on quantitative measures extracted from CT images and machine learning algorithms have not been well characterized. These technologies may affect image quality in ways that may limit the generalizability of quantitative imaging and Artificial Intelligence/Machine Learning (AI/ML) methods.  For example, advanced image reconstruction methods may be able to mitigate the increase in noise that is incurred when radiation dose is reduced, but there may be some impact on image resolution. In addition, many of these techniques are non-linear and adaptive to the local image anatomy and pathology, their impacts may be difficult to predict from application to application and even patient to patient (and yes, even within a patient). This presentation will provide examples of these effects and discuss possible methods to mitigate these effects, which hopefully will enable more generalizable deployment of quantitative imaging methods and AI/ML algorithms. 

Recording

Transcript

Report of the MIDI Task Group about best practices and recommendations for medical imaging de-identification

Dr. David Clunie (Chairperson of the MIDI Task Group)

Recording

Transcript

Slides

Bringing AI from Hype to Reality for Routine Clinical Practice:  Defining and Addressing the Gaps

Dr. Eliot Siegel, University of Maryland

Despite the ever-increasing number of publicly available imaging databases and oncology AI/Radiomics applications that have been curated and developed over the past more than 15 years, an extraordinarily small number of AI applications are available and in use for routine clinical cancer care by radiologists, oncologists, and other healthcare providers.  This is the case despite large and carefully and expertly curated and annotated databases which have been generously funded and made available by NCI and other organizations.

Mammography CAD/AI has a particularly interesting and unique history and adoption curve and while it is in widespread use throughout the US, there continues to be a large gap in accuracy between the small percentage of studies interpreted by subspecialist mammographers and the vast majority of studies interpreted by general radiologists.  This presentation will discuss some of the reasons for this continuing gap and lack of adoption of mammograph CAD into clinical decision making.

Additionally, a combination of regulatory challenges, the lack of a paradigm for training on datasets consisting of both prior and follow-up studies, brittleness of algorithms that are not adaptive, bias due in part to lack of transparency of databases used to develop AI apps, lack of standards for consumption of on prem and off prem algorithms, multiple platforms for packaging and using applications and lack of post-market surveillance, questions about whom the algorithms should be designed for, and many other factors have hampered widespread adoption.  This presentation will discuss some solutions to these challenges that could accelerate adoption of these algorithms which could substantially enhance care for oncology patients.

MP4 file

Transcript

Slides

NCI's Imaging Data Commons: Fall 2022 Update

Andrey Fedorov, Ph.D., Harvard

The NCI's Imaging Data Commons (IDC) is a cloud-based repository of publicly available cancer imaging data co-located with the analysis and exploration tools and resources. IDC is a node within the broader NCI Cancer Research Data Commons (CRDC) infrastructure that provides secure access to a large, comprehensive, and expanding collection of cancer research data. In this presentation we will cover the highlights of IDC development that took place since the production release of the repository. Among other updates, we will discuss the new datasets that have been released by IDC, new features of the platform, and the ongoing work on expanding the learning materials, including the application of IDC and cloud computing to support reproducible AI research.

A cloud-based platform for the dissemination of deep learning models

Hugo Aerts, Ph.D., Harvard MGB

Recent advances in artificial intelligence in medicine have led to a profusion of studies that apply deep learning to problems in radiology and pathology, among others. However, the effective dissemination of deep learning algorithms remains challenging, inhibiting reproducibility and benchmarking studies, impeding further validation, and ultimately hindering their effectiveness in the cumulative scientific progress. In this talk, we will discuss a platform we are developing for the structured dissemination of deep learning models that is domain-, data-, and framework-agnostic, and can cater to different workflows and contributors’ preferences. Ultimately, these efforts will bring much-needed transparency to AI and accelerate scientific discoveries, academic training, and clinical adoption of AI applications in medicine.

MP4 file

Transcript

Bridging the gap between prostate radiology and pathology through machine learning

Mirabela Rusu, PhD, Stanford University

The subtle difference in MRI appearance of prostate cancer and benign prostate tissue renders the interpretation of prostate MRI challenging, causing many false positives, false negatives, and wide variations in interpretation. My laboratory focuses on improving the interpretation of prostate MRI by developing deep learning models that automatically localize indolent and aggressive prostate cancers on MRI scans. The novelty of our methods comes from using whole-mount pathology images to label MRI images and to create pathomic MRI biomarkers of aggressive and indolent cancers. Our approach achieved an area under the receiver operator characteristics curve of 0.93 evaluated on a per-lesion basis and outperformed existing deep learning models. In patients outside our training cohorts, such predictive models will outline the extent of cancer on radiology images in the absence of pathology images, thus helping guide the prostate biopsy and local treatment.

The talk will focus on discussing recent contributions from my lab on registering whole-mount pathology images with MRI, training deep learning models to extract pathomic MRI biomarkers and using them in training deep learning models to detect and distinguish indolent and aggressive prostate cancers on MRI, and showing the benefits of using labels from pathology in training deep learning models to distinguish indolent from aggressive prostate cancer on MRI.

MP4 file

Transcript

Machine Intelligence/Data Science in Medical Imaging of Breast Cancer and COVID-19

Maryellen Giger, Ph.D, University of Chicago

Artificial Intelligence in medical imaging involves research in task-based discovery, predictive modeling, and robust clinical translation.  Quantitative radiomic analyses, an extension of computer-aided detection (CADe) and computer-aided diagnosis (CADx) methods, are yielding novel image-based tumor characteristics, i.e., signatures that may ultimately contribute to the design of patient-specific cancer diagnostics and treatments. Beyond human-engineered features, deep convolutional neural networks (CNN) are being investigated in the diagnosis of disease on radiography, ultrasound, and MRI.  The method of extracting characteristic radiomic features of a lesion and/or background can be referred to as “virtual biopsies”.  Various AI methods are evolving as aids to radiologists as a second reader or a concurrent reader, or as a primary autonomous reader.  In addition, performance evaluations, as well as considerations of robustness and repeatability, are necessary to enable translation. This presentation will discuss the development, validation, database needs, and ultimate future implementation of AI in the clinical radiology workflow including examples from breast cancer and COVID-19.  In addition, aspects of MIDRC (midrc.org) will be discussed.

MP4 file

Transcript

AI/ML Trends in Oncology and the Rugged Path Towards the Clinic

Issam El Naqa, PhD, Moffit Cancer Center

Artificial intelligence (AI) and Machine learning (ML) algorithms are currently transforming biomedical research, especially in the context of cancer research and clinical care. Despite the tremendous potentials in automating workflow, personalizing care, and reducing health disparity, to name a few prospects, their application in oncology and healthcare has been limited in scope with less than 5% of major healthcare providers implementing any form of AI/ML solutions. This can be attributed to multitude of concerning issues regarding the deployment of AI/ML driven technologies into the clinic. These concerns include but not limited to skepticism related to commercialization hype, under representative training data, inherent implementation bias, lack of robustness and absence of prediction transparency. In this work, we will discuss some of these impending challenges and highlight different approaches for detecting and mitigating such bias in implementing clinical AI/ML algorithms. We further show examples of applying these approaches in oncology applications from our work and others and discuss their implications to pave the way for AI/ML in clinical practice. 

MP4 file

Transcript

Digital twins for oncology via imaging-based mathematical modeling

Thomas Yankeelov, PhD, University of Texas Austin

Our lab is focused on integrating quantitative imaging data with mechanism-based, mathematical models to predict treatment response.  In this presentation, we will discuss some of our preliminary efforts at building digital twins to achieve this goal.  We will begin by considering the I-SPY trials for breast cancer as a specific example of how the success of adaptive, population-based clinical trials indicate that digital twins can lead to the success of adaptive, individual-based, clinical trials.  Then we will emphasize the importance of physics and biology-based mathematical models for constructing digital twins. Finally, we will illustrate how these ideas are beginning to play out in predicting and optimizing neoadjuvant therapy for breast cancer.

MP4 file

Transcript

Precision Medicine Approach to Breast Cancer Detection and Diagnosis

Martin Yaffe, PhD, Sunnybrook Research Institute and The University of Toronto

Dr. Yaffe will describe a multi-platform approach under investigation in his lab to improve the effectiveness of breast cancer detection and diagnosis. We are developing radiomic tools to guide the stratification of women for breast cancer screening that will be more accurate and efficient in detection than the “one size fits all” use of mammography whose accuracy suffers, particularly in dense breasts. We employ microsimulation modeling to guide that work. We are also exploring the integration of radiomic information from in vivo medical images with histopathology, single-cell multiplex biomarker analysis, and targeted molecular sequencing to better characterize breast and other cancers and their immune environment and to explore their spatial heterogeneity.

MP4 file

Transcript (vtt)

Transcript (txt)

NCI CCR Artificial Intelligence Resource: Recent AI Applications in Cancer Imaging

Presenters:
G. Thomas Brown, MD PhD, Staff Clinician, NCI/CCR
Stephanie Harmon, PhD, Staff Scientist, NCI/CCR
Nathan Lay, PhD, Staff Scientist, NCI/CCR

Artificial Intelligence (AI) is becoming important for cancer research but is difficult to access for most labs. In 2020, the NCI Center for Cancer Research (CCR) created a new AI Resource (AI) to benefit researchers in the CCR. The group focuses on translational computer vision approaches to analyzing medical images, such as radiologic, digital pathology, video/endoscopy and optical imaging, among others.  Examples of potential projects include developing better screening, detection methods or predictive markers, or improving procedures among many others.

With experts in pathology, medical imaging, and machine learning, AIR has taken on a diverse portfolio of research projects in their first year. In this seminar, senior members of the group will discuss its formation, collaboration experience, recent progress, and challenges for deploying developed models back to the hands of researchers across varying domains in NCI.

The presentation contained unpublished data.

As projects are finished and code is released, the AIR team will update the webpage.

https://ostr.ccr.cancer.gov/emerging-technologies/air/

You can also email the AIR team with any questions you might have (air@nih.gov)

Multiplexed Tissue Imaging to Study Cancer

Sandro Santagata, MD PhD

Our team at the Harvard Medical School’s Lab of Systems Pharmacology has generated reagents, workflows, and data analysis/visualization approaches for multiplexed tissue imaging. We developed tissue-based cyclic immunofluorescence (t-CyCIF) for subcellular imaging of formalin-fixed and paraffin-embedded (FFPE) and frozen tissues across 20-60 different proteins markers from a single tissue section. To support the use of multiplexed tissue imaging in the NCI Human Tumor Atlas Network (HTAN), we have developed algorithms and workflows to analyze these complex images, digital docents for their narrated viewing, and reporting standards for public data sharing. The information from these imaging methods complement data acquired by microregion spatial transcriptomics technologies. We have also used high-resolution imaging of tissues to identify functional interactions (e.g., immune synapses) in cancer tissues and have created multiplexed 3D cancer atlases to more completely characterize the architecture of the tumor-immune landscape in colon cancer and in melanomas, from pre-cancer lesions through metastasis.

Imaging Data Commons Production Release Update

Andrey Fedorov, PhD

The National Cancer Institute (NCI) Cancer Research DataCommons (CRDC) aims to establish a national cloud-based data science infrastructure. The goal of IDC is to enable a broad spectrum of cancer researchers, with and without imaging expertise, to easily access and explore the value of deidentified imaging data and to support integrated analyses with non-imaging data. We achieve this goal by co-locating versatile imaging collections with cloud-based computing resources and data exploration, visualization, and analysis tools. The IDC pilot was released in October 2020. In this presentation, we will give a brief overview of the capabilities of the production release of the IDC platform, and discuss the next steps for the development.

MP4 file

Transcript

Medical Imaging De-Identification Initiative (MIDI)

A DICOM dataset for evaluation of medical image de-identification

Dr. Fred Prior (UAMS)

A growing number of tools and procedures claim to properly de-identify image data. Based on our decade of experience managing the Cancer Imaging Archive (TCIA) on behalf of NCI, we developed a DICOM dataset that can be used to evaluate the performance of de-identification algorithms. DICOM objects were selected from datasets published in TCIA.  Synthetic Protected Health Information (PHI) was generated and inserted into selected DICOM Attributes to mimic typical clinical imaging exams. The DICOM Standard and TCIA curation audit logs guided the insertion of synthetic PHI into standard and non-standard DICOM data elements. An answer key was created based on our knowledge of the placement of synthetic data and the DICOM standard’s guidelines for what actions should be taken in regard to the synthetic PHI.  A TCIA curation team tested the utility of the evaluation dataset and answer key.

Medical Image De-Identification using Cloud Services

Dina Mikdadi, Dr. Benjamin Kopchick

Patient privacy rules require the removal of Protected Health Information (PHI) before sharing images publicly. Manual de-identification is no longer scalable due to the rapid increase in imaging data volume. Our goal was to configure and test the efficacy of a cloud service for automated medical image de-identification (MIDI).  One such service for DICOM images is Google Cloud Platform’s Healthcare API. Training and test datasets for validation of image de-identification, specifically prepared by the placement of synthetic PHI in DICOM headers and image pixel data, were obtained from The Cancer Imaging Archive. The customized MIDI pipeline correctly performed 99.8% of expected actions on DICOM header data elements. For image pixel data, one false-positive case was noted, while all sensitive information was correctly removed from image pixel data. Throughput averaged at 58.4 images per second. This implementation of the MIDI pipeline holds promise for automated de-identification at scale. However, verification by a human expert is still currently recommended.

MP4 file

Transcript

Establishing next generation dynamic susceptibility contrast MRI based biomarkers for neuro-oncologic applications

Dr. Chad Quarles, PhD

Dynamic susceptibility contrast (DSC) MRI is one of the most widely used physiologic imaging techniques in neuro-oncology, enabling the differentiation of glioma grades, identification of tumor components in non-enhancing glioma, reliable detection of recurrence, and early detection of therapy response. This presentation will highlight how an improved understanding of the biophysics of the contrast mechanisms underlying DSC-MRI enabled the recent standardization of acquisition protocols for multi-site clinical trials, is leading to the field’s first benchmark for software validation, and is informing the development of advanced pulse sequences and analysis strategies tailored to specific clinical challenges faced in the management of brain cancer patients. 

MP4 file

Transcript

Can you sue an algorithm?

Dr. Saurabh Jha (University of Pennsylvania, Perelman School of Medicine)

MP4 file

Transcript

Precision Surgery: Intraoperative molecular imaging to improve margin detection

Dr. Eben Rosenthal, Professor of Otolaryngology, Head & Neck Surgery and Radiology, Stanford University

Cancer is nearly always a surgically treated disease. Almost 80% of patients with early stage solid tumors undergo surgery at some point within their treatment course. A major gap in quality of care remains the high rate of tumor-positive margins in head and neck cancer (HNC) following surgical resections. Positive margin rates are directly correlated with lower survival but have remained unchanged at 25% for the last two decades! Primary factors that have impeded improving the rate of tumor-positive margins include subjective surgeon assessment as well as the limited amount of the tissue that can be sampled for intraoperative frozen-section analysis. We have demonstrated that use of intraoperative molecular imaging (IMI) can objectively identify the area on the tumor specimen most likely to contain a tumor-positive margin (“sentinel margin”). In a prospective evaluation, a fluorescently-labeled tumor-specific contrast agent is administered intravenously to the patient several days prior to surgery. After the surgical resection, the specimen is evaluated with IMI, in which near infrared imaging is used to identify the location of the sentinel margin on the surgical specimen. This evaluation is compared to subjective assessments of the deep tumor margin by palpation, considered the standard of care. It is expected that IMI imaging will be more accurate in identifying the sentinel margin, and will shorten the time to histological diagnosis while maintaining tissue orientation and high histological image quality. The translation of these new technologies has the potential to double the five-year survival rate of patients with HNC as well offer the potential to improve care for other cancer types as well. 

MP4 file

Transcript

Orchestration of distributed image archives
Jonas Almeida and Praphulla Bhawsar

Recent advances in the use of HTTP range requests to traverse bioformats*, coupled with a general move to “zero footprint” image informatics solutions, enable the creation of image archives as an exercise in governance. A particular feature of this configuration is that the images do not have to be copied or moved from their primary location. This has two interesting effects: a) the image owner remains in control of its governance, and b) training of AI classifiers can be federated across image sets that are not even shared.

* Bremer E, Saltz J, Almeida JS. ImageBox 2 – Efficient and rapid access of image tiles from whole-slide images using serverless HTTP range requests. J Pathol Inform 2020;11:29

MP4 file

Transcript

The NIAID Office of Cyber Infrastructure and Computational Biology will share their TB Portals Program, including their efforts at imaging data collection, data dissemination, tool development, and data science research. https://tbportals.niaid.nih.gov

• • • Program introduction – Alex Rosenthal
    • Demo #1 – Alyssa Long
    • Demo #2 – Andrei Gabrielian
    • Imaging data science research – Ziv Yaniv & Gabriel Rosenfeld

MP4 file

Transcript

Imaging Data Commons

Andrey Fedorov, PhD, Dennis Bontempi

MP4 file

Transcript

MONAI

Stephen Aylward, Prerna Dogra, Jorge Cardoso

• • Introduction to MONAI and the MONAI Community - Stephen Aylward

  • MONAI medical deep learning capabilities and roadmap - Jorge Cardoso 

  • MONAI and clinical workflows: Clara and federated learning - Brad Genereaux

MP4 file

Transcript

Kheops

Joël Spaltenstein, Osman Ratib

MP4 file

Transcript

Computational Imaging for Precision Medicine: A quest for generalizable AI models

Satish Viswanath

MP4 file

Transcript

Distributed Learning of Deep Learning in Medical Imaging

Daniel Rubin

• MedICI website (Benjamin Bearce)

ACR's AI-LAB

Laura Coombs, Chris Treml

PathPresenter - a web-based digital pathology and image viewer
Rajendra Singh, Matthew Hanna

HistoQC: An Open-Source Quality Control Tool for Digital Pathology Slides

Andrew Janowczyk

RIL-Contour: a Medical Imaging Dataset Annotation Tool for and with Deep Learning

Kenneth Philbrick

Advanced Methods in Tissue Cytometry

Rupert Ecker

Presentation by the 4D Necleome Imaging Working Group

David Grünwald

HTT: high-throughput truthing project

Brandon Gallas

DICOM SR for LIDC collection

Andrey Federov

Kaleidoscope: A Series Projection Visualization Tool for Review of DICOM Images for Protected Health Information

William Bennett

The SEER Virtual Tissue Repository and Pathomics

Joel Saltz 

Changes to the QIN Funding Mechanism

Bob Nordstrom

TCIA Update 

Christina Vivelo

MICCAI Conference Debrief

Keyvan Farahani

TCIA Submission Wizard

Kirk Smith

Imaging Data Commons – RFI and RFP

Steve Jett, Todd Pihl

Euro-BioImaging and the Image Data Resource

Jason Swedlow, University of Dundee

Update on the Imaging Data Commons

Todd Pihl, Steve Jett

Medici Help Desk

Jayashree Kalpathy-Cramer, Karl Helmer

Crowds Cure Cancer – project description

Justin Kirby, FNLCR

Lung Cancer Screening Challenge

Keyvan Farahani

Scientific Overview: Volumetric Computed Tomography (CT) for Precision Analysis of Clinical Trial Results (Vol-PACT)

Lawrence Schwartz

Workshop Discussions – Informatics Needs in Medical Imaging

Bob Nordstrom & Ed Helton, NCI

An Approach to Combining Disparate Clinical Study Data across multiple sponsor’s studies participating in Project DataSphere®

Gene Lightfoot, SAS

Veterans Affairs Precision Oncology Program (POP) and APOLLO activities

Luis Selva, VA

• NBIA (Scott Gustafson)
• CTIIP - Digital Pathology and Integrative Query System  (Ashish Sharma)
• CTIIP – Pilot Challenges (Jayashree Kalpathy-Cramer, Artem Mamanov)
• BRIDG (David Clunie / Ed Helton)

MAASTRO – NBIA integration with OpenClinica

• AIM DICOM SR (Daniel Rubin)
• NBIA (Scott Gustafson)
• CTIIP - Digital Pathology and Integrative Query System  (Ashish Sharma)
• CTIIP – Pilot Challenges (Jayashree Kalpathy-Cramer, Artem Mamanov)
• CTIIP – Co-clinical / Animal model data (Bob Cardiff)
• BRIDG and Imaging (David Clunie / Ed Helton)

• NBIA (Scott Gustafson)
• CTIIP - Digital Pathology and Integrative Query System  (Ashish Sharma)
• CTIIP – DICOM WG-30 (David Clunie / Joe Kalen)
• CTIIP – Pilot Challenges (Artem Mamanov)
• CTIIP – Co-clinical / Animal model data (Bob Cardiff)
• Impressions from the RSNA Meeting (Justin Kirby)
• CI4CC Workshop Update (Ashish Sharma and Ed Helton)

• NBIA (Russ Rieling)
• CTIIP - Digital Pathology and Integrative Query System (Ashish Sharma)
• CTIIP – DICOM WG-30 (David Clunie / Joe Kalen)
• CTIIP – Pilot Challenges (Artem Mamanov)
• CTIIP – Co-clinical / Animal model data (Bob Cardiff)

• NBIA (Scott Gustafson)
• CTIIP - Digital Pathology and Integrative Query System (Ashish Sharma)
• CTIIP – DICOM WG-30 (Joe Kalen)
• CTIIP – Pilot Challenges (Jayashree Kalpathy-Cramer)
• CTIIP – Co-clinical / Animal model data (Bob Cardiff)
• NBIA Refactoring Analysis Project (Lawrence Tarbox)

• NBIA (Scott Gustafson)
• NBIA Refactoring Analysis Project (Lawrence Tarbox)
• CTIIP - Digital Pathology and Integrative Query System  (Ashish Sharma)
• CTIIP – DICOM WG-30 (David Clunie)
• CTIIP – Pilot Challenges (Jayashree Kalpathy-Cramer)
• CTIIP – Co-clinical / Animal model data (Bob Cardiff)
• AIM Working Group / BRIDG and Imaging (Ed Helton)
  

• NBIA (Scott Gustafson)
• CTIIP - Digital Pathology and Integrative Query System  (Ashish Sharma)
• CTIIP – DICOM WG-30 (David Clunie)
• CTIIP – Pilot Challenges (Jayashree Kalpathy-Cramer)
• CTIIP – Co-clinical / Animal model data (Bob Cardiff)
• NBIA Refactoring Analysis (Lawrence Tarbox)
• BRIDG and the presence of Imaging (Ed Helton, Smita Hastak)

• NBIA (Scott Gustafson)
• CTIIP - Digital Pathology and Integrative Query System (Ashish Sharma)
• CTIIP – DICOM WG-30 (David Clunie)
• CTIIP – Pilot Challenges (Jayashree Kalpathy-Cramer)
• CTIIP – Co-clinical / Animal model data (Ulli Wagner)
• Outcome of the QIN/CBIIT Imaging Informatics Workshop (Ed Helton, Jose Galvez)
• AIM Working Group Update (Ulli Wagner)
• Other imaging groups on NCIP Hub (Ulli Wagner)

• NBIA (Scott Gustafson)
• CTIIP - Digital Pathology and Integrative Query System (Ashish Sharma)
• CTIIP – DICOM WG-30 (David Clunie)
• CTIIP – Pilot Challenges (Jayashree Kalpathy-Cramer)
• CTIIP – Co-clinical / Animal model data (Ulli Wagner)
• AIM Working Group Update (Daniel Rubin, Pat Mongkolwat)
• Bioinformatics Workshop (Ed Helton, Jose Galvez)

• NBIA (Scott Gustafson)
• CTIIP - Digital Pathology and Integrative Query System (Ashish Sharma)
• CTIIP – DICOM WG-30 (David Clunie)
• CTIIP – Pilot Challenges (Jayashree Kalpathy-Cramer)
• CTIIP – Co-clinical / Animal model data (Ulli Wagner)
• AIM Working Group Update (Daniel Rubin, Pat Mongkolwat)
• Bioinformatics Workshop (Ed Helton, Jose Galvez)

• NBIA (Scott Gustafson)
• CTIIP - Digital Pathology and Integrative Query System  (Ashish Sharma)
• CTIIP – DICOM WG-30 (David Clunie)
• CTIIP – Co-clinical / Animal model data (Ulli Wagner)
• CTIIP – Pilot Challenges (Jayashree Kalpathy-Cramer)
• AIM Working Group Update (Daniel Rubin, Pat Mongkolwat)